|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02123329 |
|
Date of registration:
|
20/04/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar
|
|
Scientific title:
|
Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar |
|
Date of first enrolment:
|
February 2013 |
|
Target sample size:
|
250 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT02123329 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Qatar
| | | | | | | |
|
Contacts
|
|
Name:
|
Maguy S El Hajj, PharmD |
|
Address:
|
|
|
Telephone:
|
0097444035577 |
|
Email:
|
maguyh@qu.edu.qa |
|
Affiliation:
|
|
|
|
Name:
|
Maguy S El Hajj, PharmD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Qatar University |
| |
|
Key inclusion & exclusion criteria
|
Eligible participants are:
- patients aged 18 years and older who currently smoke one or more cigarettes daily for
7 days, are motivated to quit i.e.: in the preparation stage of the stage-of-change
model, able to communicate in Arabic or English and are willing and capable of
attending the scheduled sessions at the study pharmacies.
Exclusion criteria are:
- use of other nicotine or tobacco products
- current use or use in the last 30 days of quit smoking aids or medications
- plan to leave Qatar in the next 12 months
- presence of any major medical condition that would prevent use of the nicotine
replacement therapy including hypersensitivity to the products, history of or recent
myocardial infarction, life-threatening arrhythmias, severe or worsening angina,
uncontrolled hypertension and temporomandibular joint disease (in case of nicotine
gum)
- pregnancy
- psychiatric illness or other debilitating condition that would interfere with
participation in the study.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Smoking Cessation
|
|
Intervention(s)
|
|
Other: Control arm (i.e: regular care)
|
|
Behavioral: Pharmacist delivered smoking cessation program
|
|
Primary Outcome(s)
|
|
Self-reported 30-day point prevalence abstinence
[Time Frame: 3 months]
|
|
Self-reported 7-day point prevalence abstinence
[Time Frame: 6 months]
|
|
Self-reported continuous abstinence
[Time Frame: 12 months]
|
|
Self-reported continuous abstinence
[Time Frame: 6 months]
|
|
Objective smoking abstinence
[Time Frame: 12 months]
|
|
Self-reported 7-day point prevalence abstinence
[Time Frame: 3 months]
|
|
Self-reported 30-day point prevalence abstinence
[Time Frame: 12 months]
|
|
Self-reported 30-day point prevalence abstinence
[Time Frame: 6 months]
|
|
Self-reported 7-day point prevalence abstinence
[Time Frame: 12 months]
|
|
Self-reported continuous abstinence
[Time Frame: 3 months]
|
|
Secondary Outcome(s)
|
|
Health related quality of life
[Time Frame: at 6 months]
|
|
Secondary ID(s)
|
|
NPRP 4 - 716 - 3 - 203
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|